These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4807979)

  • 1. [Study of bovine sera by micro-complement fixation test for taxoplasmosis].
    Doğuer M
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):103-17. PubMed ID: 4807979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conjugation of toxoplasma antibody-containing sera with fluorescein isothiocyanate. Complement fixation test, indirect fluorescent antibody reaction and serum dye test as test criteria for the sera to be selected].
    Budde E
    Zentralbl Bakteriol Orig; 1970; 213(2):263-9. PubMed ID: 4918992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxoplasmin reactivity and positivity for the dye test and complement fixation in apparently healthy persons from the provinces Ciudad de la Habana and La Habana. Review of the bibliography].
    Delgado García G
    Rev Cubana Med Trop; 1983; 35(3):338-44. PubMed ID: 6379778
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and properties of anti-sulfatide serum.
    Hakomori S
    J Immunol; 1974 Jan; 112(1):424-6. PubMed ID: 4855831
    [No Abstract]   [Full Text] [Related]  

  • 5. Verification of tween-ether antigen for complement fixation test in the diagnostics of toxoplasmosis.
    Pokorný J; Frühbauer Z; Curík B; Zástĕra M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):353-6. PubMed ID: 575152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanization of a micro complement fixation test for the serodiagnosis of human toxoplasmosis.
    Ruitenberg EJ; Buys J; Meeuwsen F
    Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):561-4. PubMed ID: 769420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement fixation inhibition test with sera from chickens experimentally infected with toxoplasms.
    HARBOE A; REENAAS R
    Acta Pathol Microbiol Scand; 1957; 41(6):511-6. PubMed ID: 13497695
    [No Abstract]   [Full Text] [Related]  

  • 8. The bovine immune response to Brucella abortus. III. Preparation of antisera against a Brucella component precipitated by sera of some infected cattle.
    Stemshorn B; Nielsen K; Samagh B
    Can J Comp Med; 1981 Jan; 45(1):77-81. PubMed ID: 6791797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in the modified direct complement fixation test and its application in the detection of bluetongue antibodies in cattle and sheep sera.
    Carrier SP; Boulanger P
    Can J Comp Med; 1975 Apr; 39(2):231-3. PubMed ID: 164994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phenol on card-agglutination and complement-fixation tests for bovine anaplasmosis.
    Amerault TE; Rose JE; Martin WE; Roby TO
    Am J Vet Res; 1980 Mar; 41(3):435-8. PubMed ID: 7369620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement fixation test in toxoplasmosis. V. Balancing of the titration scales of the amboceptor and of the complement. Effect of differentiated complement doses on the determination of the antigen titre and of the anticomplementary activity].
    Bozdĕch V; Jíra J
    Cesk Epidemiol Mikrobiol Imunol; 1968 May; 17(3):139-49. PubMed ID: 4231697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complement fixation test technics in the diagnosis of cattle brucellosis. I. Effect of time and temperature on sensitivity of the test].
    Królak M
    Pol Arch Weter; 1974; 17(3):399-408. PubMed ID: 4216012
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the toxoplasmin skin tests, the Sabin-Feldman dye tests, and the complement fixation tests for toxoplasmosis in various forms of uveitis.
    HOOVER R; JACOBS L; NAQUIN H; WOODS AC
    Trans Am Acad Ophthalmol Otolaryngol; 1956; 60(5):655-71. PubMed ID: 13380882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxoplasma antigens].
    Berger J; Jírovec O
    Zentralbl Bakteriol Orig; 1968; 209(1):120-8. PubMed ID: 5754716
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the animal toxoplasmosis reservoir by means of the complement fixation test].
    UMINSKI J; TOS-LUTY S; STROCZYNSKA M; BAZYLSKA D
    World Wide Abstr Gen Med; 1961; 7(2)Suppl():413-6. PubMed ID: 13779158
    [No Abstract]   [Full Text] [Related]  

  • 16. Further attainments in the standardization of the complement fixation test (CFT) in brucellosis. I. Standard serum and standardized reference bacteriolysin.
    Anczykowski F
    Pol Arch Weter; 1982; 23(2):7-11. PubMed ID: 6820143
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation in gnotobiotic animals of monospecific reference serums against viruses.
    Christofinis GJ; Edington N; Betts AO; Prydie J; Pirie G
    Am J Vet Res; 1972 Oct; 33(10):1915-23. PubMed ID: 4342330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specificity and sensitivity of the fluorescent antibody technic, complement fixation test and intradermal allergic test in toxoplasmosis].
    Kovaleva EP; Ptashka EM; Samokhina LI
    Lab Delo; 1976; (5):297-301. PubMed ID: 62091
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the problems concerning acute acquired toxoplasmosis. (Effects of therapy and intradermal test on the dynamics of the complement fixation test].
    KOUBA K; BENDOVA N; BOZDECH V
    Z Gesamte Inn Med; 1962 Mar; 17():265-8. PubMed ID: 14458847
    [No Abstract]   [Full Text] [Related]  

  • 20. Further attainments on the standardization of the complement fixation test (CFT) in brucellosis. IV. Techniques.
    Anczykowski F
    Pol Arch Weter; 1982; 23(2):37-49. PubMed ID: 6820142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.